These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37747445)

  • 1. Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
    Hanarz M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Malinowski KP; Gajos G
    Adv Clin Exp Med; 2024 Jun; 33(6):593-600. PubMed ID: 37747445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
    Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
    Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
    Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Lipoprotein-Associated Phospholipase A
    Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
    Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 activity in obese adolescents with and without type 2 diabetes.
    Seyfarth J; Reinehr T; Hoyer A; Reinauer C; Bächle C; Karges B; Mayatepek E; Roden M; Hofer SE; Wiegand S; Woelfle J; Kiess W; Rosenbauer J; Holl RW; Meissner T
    J Inherit Metab Dis; 2018 Jan; 41(1):73-79. PubMed ID: 29027597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A
    Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L
    Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.
    De Mauri A; Vidali M; Chiarinotti D; Bellomo G; Rolla R
    J Nephrol; 2019 Apr; 32(2):283-288. PubMed ID: 30168082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
    Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
    Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized phospholipids and lipoprotein-associated phospholipase A
    Pantazi D; Tellis C; Tselepis AD
    Biofactors; 2022 Nov; 48(6):1257-1270. PubMed ID: 36192834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
    Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
    Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
    Ling Y; Tang S; Cao Y; Fu C
    Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-3 and n-6 Fatty acids are independently associated with lipoprotein-associated phospholipase A2 in the Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Steffen LM; Liang S; Tracy R; Jenny NS; Tsai MY
    Br J Nutr; 2013 Nov; 110(9):1664-71. PubMed ID: 23551952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes.
    Cai R; Huang R; Han J; Sun H; Sun J; Xia W; Tian S; Dong X; Shen Y; Wang S
    Sci Rep; 2017 Sep; 7(1):12311. PubMed ID: 28951620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.